PubMed

The changing face of HIV/AIDS in treated patients.

Llibre JM, Falco V, Tural C, Negredo E, Pineda JA, Muñoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ, Domingo P, d'Arminio-Monforte A, Miro JM, Clotet B.

Curr HIV Res. 2009 Jul;7(4):365-77. Review.PMID: 19601771 [PubMed - indexed for MEDLINE]Related articles

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.

Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, Mallolas J, Sanz J, Tural C, Bellón JM, González-García J; GESIDA3603/5607 Study Group.

Hepatology. 2009 Aug;50(2):407-13.PMID: 19575364 [PubMed - indexed for MEDLINE]Related articles

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)]

Caro-Murillo AM, Gutiérrez F, Manuel Ramos J, Sobrino P, Miró JM, López-Cortés LF, Tural C, Moreno A, de Los Santos I, Murillas J, Camino X, Salavert M, Rubio R, Moreno S, del Amo J; CoRIS.

Enferm Infecc Microbiol Clin. 2009 Aug-Sep;27(7):380-8. Epub 2009 May 8. Spanish. PMID: 19427080 [PubMed - in process]Related articlesFree article

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.

Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, del Amo J, Moreno S; CoRIS.

Curr HIV Res. 2009 Mar;7(2):224-30.PMID: 19275591 [PubMed - indexed for MEDLINE]Related articles

Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.

Tural C, Galeras JA, Planas R, Coll S, Sirera G, Giménez D, Salas A, Rey-Joly C, Cirera I, Márquez C, Tor J, Videla S, García-Retortillo M, Clotet B, Solà R.

Antivir Ther. 2008;13(8):1047-55.PMID: 19195330 [PubMed - indexed for MEDLINE]Related articles

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.

Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B.

Clin Gastroenterol Hepatol. 2009 Mar;7(3):339-45. Epub 2008 Dec 3.PMID: 19171202 [PubMed - indexed for MEDLINE]Related articles

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.

Laguno M, Cifuentes C, Murillas J, Veloso S, Larrousse M, Payeras A, Bonet L, Vidal F, Milinkovic A, Bassa A, Villalonga C, Pérez I, Tural C, Martínez-Rebollar M, Calvo M, Blanco JL, Martínez E, Sánchez-Tapias JM, Gatell JM, Mallolas J.

Hepatology. 2009 Jan;49(1):22-31. Erratum in: Hepatology. 2009 Mar;49(3):1058. PMID: 19085908 [PubMed - indexed for MEDLINE]Related articles

The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.

Darwich L, Cabrera C, Romeu J, Martinez-Picado J, Esté JA, Tural C, Bellido R, Clotet B, Angulo A, Ruiz L, Bofill M.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):507-12.PMID: 18989229 [PubMed - indexed for MEDLINE]Related articles

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.

Mira JA, López-Cortés LF, Barreiro P, Tural C, Torres-Tortosa M, de Los Santos Gil I, Martín-Rico P, Ríos-Villegas MJ, Hernández-Burruezo JJ, Merino D, López-Ruz MA, Rivero A, Muñoz L, González-Serrano M, Collado A, Macías J, Viciana P, Soriano V, Pineda JA.

J Antimicrob Chemother. 2008 Dec;62(6):1365-73. Epub 2008 Oct 13.PMID: 18854330 [PubMed - indexed for MEDLINE]Related articles

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).

Jaén A, Esteve A, Miró JM, Tural C, Montoliu A, Ferrer E, Riera M, Segura F, Force L, Sued O, Vilaró J, Garcia I, Masabeu A, Altès J, Coltet B, Podzamczer D, Murillas J, Navarro G, Gatell JM, Casabona J; PISCIS Study Group.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):212-20.PMID: 18297762 [PubMed - indexed for MEDLINE]Related articles

Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.

Kuntzen T, Tural C, Li B, Feldmann G, Kupfer B, Nischalke HD, Clotet B, Sauerbruch T, Rockstroh JK, Spengler U.

AIDS. 2008 Jan 11;22(2):203-10.PMID: 18097222 [PubMed - indexed for MEDLINE]Related articles

Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.

Sirera G, Videla S, López-Blázquez R, Llatjos M, Tarrats A, Castellà E, Grane N, Tural C, Rey-Joly C, Clotet B.

J Antimicrob Chemother. 2008 Jan;61(1):191-4. Epub 2007 Oct 31.PMID: 17977910 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of HIV/hepatitis C virus-coinfected patient non-responders to hepatitis C virus antiviral therapy and relapsers.

Tural C, Planas R, Sirera G, Clotet B.

Curr Opin HIV AIDS. 2007 Nov;2(6):496-502.PMID: 19372933 [PubMed - as supplied by publisher]Related articles

[Risk of transmission of HIV or hepatitis B or C viruses from an infected physician. Preventive measures]

Bruguera M, Torres M, Campins M, Bayas JM, Segura A, Barrio JL, Esteban R, Gatell JM, Martínez M, Monés J, Plans A, Planas R, Serra C, Tural C, Villalbí JR.

Med Clin (Barc). 2007 Sep 8;129(8):309-13. Review. Spanish. No abstract available. PMID: 17878027 [PubMed - indexed for MEDLINE]Related articles

Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.

Sirera G, Videla S, López-Blázquez R, Llatjos M, Tarrats A, Castellà E, Grane N, Alcalde C, Tural C, Rey-Joly C, Clotet B.

AIDS Res Hum Retroviruses. 2007 Aug;23(8):965-71.PMID: 17725412 [PubMed - indexed for MEDLINE]Related articles

Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: is it really different, and if so, why?

Degos F, Tural C.

J Hepatol. 2007 Oct;47(4):447-50. Epub 2007 Jul 27. No abstract available. PMID: 17692426 [PubMed - indexed for MEDLINE]Related articles

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection.

Dore GJ, Torriani FJ, Rodriguez-Torres M, Bräu N, Sulkowski M, Lamoglia RS, Tural C, Clumeck N, Nelson MR, Mendes-Correa MC, Godofsky EW, Dieterich DT, Yetzer E, Lissen E, Cooper DA.

AIDS. 2007 Jul 31;21(12):1555-9.PMID: 17630550 [PubMed - indexed for MEDLINE]Related articles

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

Moltó J, Valle M, Blanco A, Negredo E, DelaVarga M, Miranda C, Miranda J, Domingo P, Vilaró J, Tural C, Costa J, Barbanoj MJ, Clotet B.

Clin Pharmacokinet. 2007;46(1):85-92.PMID: 17201460 [PubMed - indexed for MEDLINE]Related articles

Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1.

Franco S, Tural C, Clotet B, Martínez MA.

Virus Res. 2007 Feb;123(2):161-9. Epub 2006 Oct 4.PMID: 17023084 [PubMed - indexed for MEDLINE]Related articles

Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.

Fuster D, Planas R, Gonzalez J, Force L, Cervantes M, Vilaró J, Roget M, García I, Pedrol E, Tor J, Ballesteros AL, Salas A, Sirera G, Videla S, Clotet B, Tural C.

Antivir Ther. 2006;11(4):473-82. Erratum in: Antivir Ther. 2006;11(5):667. PMID: 16856621 [PubMed - indexed for MEDLINE]Related articles